CorVista Health
Healthcare Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
160 Bloor St. East Ste 910, Toronto, Ont...Phone Number
(202) 722-6451Website
www.corvista.comRevenue
$10 MillionIndustry
About CorVista Health
CorVista Health Org Chart
Is CorVista Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CorVista Health is spiking on competitors!
Check if CorVista Health has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once CorVista Health has new funding data
Earning: See what the market has to say on CorVista Health recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CorVista Health launches new products
Click to see if CorVista Health had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CorVista Health
CorVista Health, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined CorVista Health as Masked Content
Find 2 more new buyers
Compare Similar Companies to CorVista Health
Compare insights from companies similar to CorVista Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CorVista Health
Company Profile Activity
Activity Insights
CorVista Health is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
CorVista Health is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about CorVista Health.
CorVista Health financials insights
Gather financial insights about CorVista Health, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$11M
Series B
$19.5M
Series C
$65M
CorVista Health Tech Stack
A closer look at the technologies used by CorVista Health
Most Recent Scoops
CorVista Health News & Media
CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension
Case series demonstrates the CorVista System®’s clinical utility in identifying pulmonary hypertension (PH) earlier, including where existing standard of care failed to raise suspicion Case series demonstrates the CorVista System®’s clinical utility in identifying pulmonary hypertension (PH) earlier, including where existing standard of care failed to raise suspicionAnalytics For Life Completes Clinical Study of Non-Invasive Point-of-Care Test for Elevated Pulmonary Capillary Wedge Pressure (PCWP) Using Machine Learning
TORONTO and BETHESDA, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, today announced the successful completion of the clinical study evaluating a machine learning-based algorithm for non-invasively identifying patients with elevated pulmonary capillary wedge pressure (PCWP) – a key indicator of both heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The stuCorVista Health Announces European Respiratory Journal Publication Detailing Validation of its Non-Invasive Test for Pulmonary Hypertension
BETHESDA, Md., May 07, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced the publication of data in European Respiratory Journal (ERJ) Open Research, a leading peer-reviewed journal. The study validates CorVista’s machine learned, non-invasive algorithm for aiding in the diagnosis of pulmonary hypertension (PH) using signals collected by the CorVista System®, the world’s first non-invasive point-of-care solution for evaluating both coronary artery disease and pulmonary hypertension.CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
BETHESDA, Md., March 31, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced a poster presentation showcasing preliminary results of its machine learning-based algorithm for non-invasively estimating pulmonary capillary wedge pressure (PCWP) elevation – a key indicator of heart failure with preserved ejection fraction. The poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American Colleg
Top Healthcare Services Companies
Frequently Asked Questions Regarding CorVista Health
Analytics 4 Life is pioneering digital health using artificial intelligence to develop a completely new form of medical imaging. With an initial focus on coronary artery disease and pulmonary hypertension, Analytics 4 Life is advancing a novel, radiation-free, and exercise-free cardiac imaging technology aimed at improving existing care pathways. A... Read More